Stock listing

Dexcom, Inc.

Selected listing: D1EX34 · BMFBOVESPA · BRL · BR

Dexcom, Inc. (B3:D1EX34), Health Technology. Latest release Oct 6, 2026: Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among…

D1EX34:BMFBOVESPABRLBRUpdated October 2, 2026

Ticker: B3:D1EX34
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: B3
Currency: BRL

About Dexcom, Inc.

Dexcom, Inc. (Ticker: DXCM) is a public company based in America, specializing in continuous glucose monitoring systems for diabetes management. The company focuses on providing real-time glucose data to empower users in their health management.

Latest news from Dexcom, Inc.

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

October 6, 2026

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

September 28, 2026

Dexcom Promotes Jereme Sylvain to Chief Operating Officer

September 14, 2026

Dexcom Appoints Glenn Boehnlein to Board of Directors

September 10, 2026

Dexcom Reports Second Quarter 2026 Financial Results

July 29, 2026

All Dexcom, Inc. news →

Events

Replays

DexCom, Inc. (DXCM) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 04:30 PM ET
Watch
DexCom, Inc. (DXCM) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 04:30 PM ET
Watch
DexCom, Inc. (DXCM) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 04:30 PM ET
Watch

Research Dexcom, Inc.

Dexcom, Inc. company profile

View the public company page for Dexcom, Inc. on 6ix.

Dexcom, Inc. news

Read company news and market updates connected to Dexcom, Inc..

Dexcom, Inc. investor events

Find investor webinars, events, and replay context for Dexcom, Inc..